Physician profile
Steven Argumedo
NPI 1780864751
$4,776.36
in general payments reported to CMS, 2019-2025
28 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,925 · 2020: $1,490 · 2022: $141 · 2023: $113 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $759.87 | 2019-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $645.54 | 2019-2020 | |
| Glaxosmithkline, LLC. | $468.80 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $401.81 | 2019-2020 | |
| Lilly USA, LLC | $398.50 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $317.95 | 2019-2020 | |
| Allergan, INC. | $305.38 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $234.96 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $231.16 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $211.24 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $159.98 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.13 | 2019-2020 | |
| Abbott Laboratories | $89.63 | 2020-2025 | Freestyle Libre 3 |
| Arbor Pharmaceuticals, INC. | $83.25 | 2019-2020 | |
| Pfizer INC. | $60.37 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $37.26 | 2019 | |
| Amgen INC. | $36.58 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $31.39 | 2019-2020 | |
| Astellas Pharma US INC | $28.51 | 2019-2020 | |
| Exact Sciences Corporation | $21.92 | 2025 | The Cologuard Plus Collection Kit |
| Globus Medical, INC. | $19.44 | 2025 | Senza |
| Corcept Therapeutics | $17.77 | 2019 | |
| Amarin Pharma, INC. | $17.45 | 2019 | |
| Insulet Corporation | $16.95 | 2025 | Omnipod |
| Intuitive Surgical, INC. | $13.48 | 2019 | |
| Acclarent, INC | $13.00 | 2019 | |
| Sanofi Pasteur INC. | $12.61 | 2019 | |
| Ironwood Pharmaceuticals, INC | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Argumedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.